Anemia, Hypochromic Microcytic, With Iron Overload
|
0.630 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the human SLC11A2 gene coding DMT1 lead to microcytic anemia and hepatic iron overload, with unexpectedly low levels of plasma ferritin in the presence of iron stores.
|
21871825 |
2011 |
Anemia, Hypochromic Microcytic, With Iron Overload
|
0.630 |
GermlineCausalMutation
|
disease |
ORPHANET |
Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2).
|
16160008 |
2006 |
Anemia, Hypochromic Microcytic, With Iron Overload
|
0.630 |
GeneticVariation
|
disease |
BEFREE |
A novel R416C mutation in human DMT1 (SLC11A2) displays pleiotropic effects on function and causes microcytic anemia and hepatic iron overload.
|
16584902 |
2006 |
Anemia, Hypochromic Microcytic, With Iron Overload
|
0.630 |
GeneticVariation
|
disease |
BEFREE |
Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2).
|
16160008 |
2006 |
Anemia, Hypochromic Microcytic, With Iron Overload
|
0.630 |
GermlineCausalMutation
|
disease |
ORPHANET |
Two new human DMT1 gene mutations in a patient with microcytic anemia, low ferritinemia, and liver iron overload.
|
16439678 |
2006 |
Anemia, Hypochromic Microcytic, With Iron Overload
|
0.630 |
Biomarker
|
disease |
CTD_human |
|
|
|
Anemia, Hypochromic Microcytic, With Iron Overload
|
0.630 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1
|
0.500 |
GeneticVariation
|
disease |
UNIPROT |
Two new human DMT1 gene mutations in a patient with microcytic anemia, low ferritinemia, and liver iron overload.
|
16439678 |
2006 |
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Two new human DMT1 gene mutations in a patient with microcytic anemia, low ferritinemia, and liver iron overload.
|
16439678 |
2006 |
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1
|
0.500 |
GeneticVariation
|
disease |
UNIPROT |
Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2).
|
16160008 |
2006 |
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload.
|
15459009 |
2005 |
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1
|
0.500 |
GeneticVariation
|
disease |
UNIPROT |
Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload.
|
15459009 |
2005 |
Hereditary hemochromatosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Hence, intestinal Dmt1 is required for the excessive iron absorption that typifies HH.
|
30713087 |
2019 |
Hereditary hemochromatosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
The principal or only intestinal nonheme-iron transporter, DMT1 is a validated therapeutic target in hereditary hemochromatosis (HHC) and other iron-overload disorders.
|
23177986 |
2012 |
Hereditary hemochromatosis
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
In summary, phlebotomy is associated with upregulation of DMT1(IRE) expression in HH subjects.
|
19892936 |
2010 |
Hereditary hemochromatosis
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
A therapeutic approach for HH could start with a long-term reduction of iron transport by reduction of DMT-1 levels.
|
15896335 |
2005 |
Hereditary hemochromatosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Polymorphisms within DMT1 gene do not influence penetrance of the HH phenotype.
|
15223008 |
2005 |
Hereditary hemochromatosis
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
DMT1 expression was significantly increased in HH patients who had undergone phlebotomy therapy (treated) and in patients with ID compared with controls.
|
15247188 |
2004 |
Hereditary hemochromatosis
|
0.400 |
Biomarker
|
disease |
BEFREE |
An increased duodenal expression of the iron transporters, divalent-metal-transporter-1, and ferroportin is observed in patients with iron deficiency or hereditary hemochromatosis.
|
12949720 |
2003 |
Hereditary hemochromatosis
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
In HFE associated hereditary haemochromatosis, the duodenal enterocyte behaves as if iron deficient and previous reports have shown increased duodenal expression of divalent metal transporter 1 (DMT1) and iron regulated gene 1 (Ireg1) in affected subjects.
|
12801950 |
2003 |
Hereditary hemochromatosis
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
In contrast, DMT-1 mRNA levels were at least twofold greater in patients with hereditary hemochromatosis and iron deficiency anemia when compared to controls (P = 0.02, P = 0.01, respectively).
|
12547214 |
2003 |
Hereditary hemochromatosis
|
0.400 |
Biomarker
|
disease |
CTD_human |
Divalent metal transporter 1 (DMT1) is a transmembrane, proton-coupled metal ion transporter that is upregulated in the duodenum of iron-deficient rodents and in hereditary hemochromatosis patients, suggesting that it may constitute a key factor in the uptake of dietary iron.
|
11439223 |
2001 |
Hereditary hemochromatosis
|
0.400 |
PosttranslationalModification
|
disease |
BEFREE |
Our study did not find evidence for the involvement of the Nramp2 gene in hereditary hemochromatosis.
|
11042033 |
2000 |
Hereditary hemochromatosis
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
We investigated the expression of NRAMP-2 in patients with hereditary haemochromatosis.
|
10382697 |
1999 |
Iron deficiency anemia
|
0.350 |
Biomarker
|
disease |
BEFREE |
Initial experiments using duodenal epithelial organ cultures from intestine-specific Dmt1 knockout (KO) (Dmt1<sup>int/int</sup>) mice in the Ussing chamber established that Dmt1 is the only active iron importer during iron-deficiency anemia.
|
30713087 |
2019 |